(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

MOLÉCULAS DE ANTAGONISTA DE FCRN E MÉTODOS DE USO DAS MESMAS

Em AnáliseInvention PatentPCT · IB2023000696

Application data

Number

112025009496

Type

Invention Patent

Filing

11/14/2023

Publication

12/09/2025

PCT

IB2023000696

Progress at the INPI

Examination not yet requested
  1. Filing11/14/23
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

Examination has not been requested yet. Without that request by 11/14/2026, the application is definitively abandoned (art. 33 of the Brazilian IP Act).

Deadline to request examination:11/14/2026(81 days left)

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 12/09/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

ARGENX BV

BE

See this company's full portfolio

Inventors

F. B. (pessoa física)

BE

H. S. (pessoa física)

BE

K. M. (pessoa física)

BE

V. H. (pessoa física)

BE

Technical data

IPC Classification

Priority claims

US

63/383,599 · 11/14/2022

Abstract

MOLÉCULAS DE ANTAGONISTA DE FCRN E MÉTODOS DE USO DAS MESMAS. A divulgação fornece populações de moléculas de antagonistas de FcRn, misturas dessas populações e métodos de uso dessas populações para reduzir o nível de autoanticorpos de IgG sérica em um sujeito.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

12/09/2025

RPI 2866

Alteração de dados cadastrais

#1.1

06/10/2025

RPI 2840

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.